0	1	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 5), 'text':'Identification of Golgi localized acyl transferases'}, {'start':(0, 6), 'end':(0, 13), 'text':'that palmitoylate and regulate endothelial nitric oxide synthase'}]}
9	33	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Introduction'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 17), 'text':'The production of nitric oxide ( NO ) by the vascular endothelium is important for cardiovascular homeostasis ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 18), 'end':(1, 26), 'text':'as endogenous NO regulates many fundamental cellular processes ,'}, {'start':(1, 27), 'end':(1, 37), 'text':'including growth , mitochondrial respiration , differentiation , and migration .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 7), 'text':'Endothelial NO synthase ( eNOS or NOS3 )'}, {'label':'joint', 'direction':'None', 'children':[{'start':(2, 8), 'end':(2, 17), 'text':'synthesizes NO in the endothelium lining all blood vessels ,'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 18), 'end':(2, 27), 'text':'and genetic deletion of eNOS causes many cardiovascular phenotypes ,'}, {'start':(2, 28), 'end':(2, 39), 'text':'including increased blood pressure , impaired angiogenesis , abnormal vascular remodeling ,'}]}, {'start':(2, 40), 'end':(2, 45), 'text':'and accelerated atherosclerosis ( ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 5), 'text':'eNOS is a peripheral membrane protein'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 6), 'end':(3, 11), 'text':'that is modified by dual acylation'}, {'start':(3, 12), 'end':(3, 19), 'text':'( N myristoylation and S palmitoylation ) ,'}]}, {'start':(3, 20), 'end':(3, 29), 'text':'which targets it to specific biological membranes ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 4), 'text':'All dually acylated proteins ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 5), 'end':(4, 20), 'text':'including eNOS , src family members , and certain G protein alpha subunits are cotranslationally N'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 21), 'end':(4, 24), 'text':'myristoylated on cytoplasmic ribosomes'}, {'start':(4, 25), 'end':(4, 30), 'text':'followed by posttranslational cysteine palmitoylation .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 2), 'text':'eNOS is N'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 3), 'end':(5, 8), 'text':'myristoylated at glycine-2 and posttranslational S'}, {'start':(5, 9), 'end':(5, 15), 'text':'palmitoylated on cysteines 15 and 26 .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 21), 'text':'N myristoylation and S palmitoylation mediate localization of eNOS to the Golgi complex and cholesterol rich microdomains of the plasma membranes ,'}, {'start':(6, 22), 'end':(6, 27), 'text':'including caveolae and lipid rafts .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 4), 'text':'Acylation defective mutants of eNOS'}, {'start':(7, 5), 'end':(7, 10), 'text':'that can not target either domain'}]}, {'start':(7, 11), 'end':(7, 18), 'text':'impair basal and agonist stimulated NO release .'}]}]}]}, {'start':(8, 0), 'end':(8, 13), 'text':'Little is known about the enzymatic mechanisms for dual palmitoylation in mammalian cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'explanation', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 6), 'text':'This fatty acid modification is reversible ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 7), 'end':(9, 10), 'text':'unlike N myristoylation ,'}, {'start':(9, 11), 'end':(9, 16), 'text':'which is permanent ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 11), 'text':'In the context of eNOS , palmitate turnover is 45 min ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 12), 'end':(10, 25), 'text':'whereas myristate turnover occurs with the protein backbone ( both ~ 20 h ;'}, {'start':(10, 26), 'end':(10, 27), 'text':') .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 11), 'text':'Palmitoylation and depalmitoylation of proteins may be regulated by extracellular signals ,'}, {'start':(11, 12), 'end':(11, 21), 'text':'providing a mechanism for dynamic regulation of protein localization .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 8), 'text':'Recently , a new family of acyl transferase enzymes'}, {'start':(12, 9), 'end':(12, 18), 'text':'that catalyzed the protein palmitoylation was discovered ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 22), 'text':'Genetic screens in yeast identified Erf2 and 4 ( ) and Akr1p ( ) as palmitoyl transferases for yeast Ras2 and casein kinase2'}, {'start':(13, 23), 'end':(13, 26), 'text':'( Yck2 ) .'}]}]}, {'start':(14, 0), 'end':(14, 15), 'text':'Deletion of Erf2 and 4 or Ark1 reduces palmitoylation of Ras2 or Yck2 , respectively .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 25), 'text':'Erf2 and 4 or Ark1 share a common region , the Asp-His-His-Cys motif ( DHHC ) , within a cysteine rich domain ( CRD ) .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 10), 'text':'The DHHC and CRD domains are essential for palmitoyl acyl transferase'}, {'start':(16, 11), 'end':(16, 15), 'text':'( PAT ) activity .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 19), 'text':'The human homologues of the yeast Erf2 and Erf4 complex are DHHC-9 and a Golgi localized protein designated GCP16 .'}, {'start':(18, 0), 'end':(18, 14), 'text':'This complex has been shown to palmitoylate H- and N-Ras in vitro ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 1), 'text':'23 genes'}, {'start':(19, 2), 'end':(19, 17), 'text':'encoding proteins with DHHC-CRD domains have been identified in mouse and human databases ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 44), 'text':'Some of these proteins are known as Golgi specific DHHC zinc finger protein ( GODZ and DHHC -3 ; ) , the c-Abl-associated protein Abl-philin2 ( Aph2 and DHHC -16 ; ) , Sertoli cell DHHC protein ( SERZ-beta and DHHC -7 ; ) ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 45), 'end':(20, 59), 'text':'Huntingtin interacting protein 14 ( HIP14 and DHHC -17 ; ) , and DHHC-15 ,'}, {'start':(20, 60), 'end':(20, 69), 'text':'which palmitoylates the neuronal scaffold protein PSD-95 ( ) .'}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 10), 'text':'In the present work , we screened the 23 known DHHCs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 11), 'end':(21, 12), 'text':'to examine'}, {'start':(21, 13), 'end':(21, 18), 'text':'which isoforms can palmitoylate eNOS .'}]}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(22, 0), 'end':(22, 1), 'text':'We found'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 2), 'end':(22, 29), 'text':'that five mammalian DHHC proteins ( DHHC-2 , -3 , -7 , -8 , and -21 ) palmitoylate eNOS , are present in human umbilical vein endothelial cells'}, {'start':(22, 30), 'end':(22, 33), 'text':'( HUVECs ) ,'}]}, {'start':(22, 34), 'end':(22, 42), 'text':'and colocalize with eNOS on the Golgi apparatus .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 8), 'text':'Finally , inhibition of DHHC-21 reduces eNOS palmitoylation ,'}, {'start':(23, 9), 'end':(23, 11), 'text':'mislocalizes eNOS ,'}]}, {'start':(23, 12), 'end':(23, 19), 'text':'and antagonizes NO release from endothelial cells .'}]}]}]}]}]}
1	9	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 12), 'text':'Lipid modifications mediate the subcellular localization and biological activity of many proteins ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 13), 'end':(0, 17), 'text':'including endothelial nitric oxide synthase'}, {'start':(0, 18), 'end':(0, 21), 'text':'( eNOS ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(1, 0), 'end':(1, 13), 'text':'This enzyme resides on the cytoplasmic aspect of the Golgi apparatus and in caveolae'}, {'start':(1, 14), 'end':(1, 25), 'text':'and is dually acylated by both N myristoylation and S palmitoylation .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 12), 'text':'Palmitoylation deficient mutants of eNOS release less nitric oxide ( NO ) .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 2), 'text':'We identify enzymes'}, {'start':(3, 3), 'end':(3, 8), 'text':'that palmitoylate eNOS in vivo .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 10), 'text':'Transfection of human embryonic kidney 293 cells with the complementary DNA'}, {'start':(4, 11), 'end':(4, 13), 'text':'( cDNA )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 14), 'end':(4, 19), 'text':'for eNOS and 23 cDNA clones'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 20), 'end':(4, 23), 'text':'encoding the Asp-His-His-Cys motif'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 24), 'end':(4, 31), 'text':'( DHHC ) palmitoyl transferase family members showed'}, {'start':(4, 32), 'end':(4, 58), 'text':'that five clones ( 2 , 3 , 7 , 8 , and 21 ) enhanced incorporation of [ 3 H ] - palmitate into eNOS .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 9), 'text':'Human endothelial cells express all five of these enzymes ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 10), 'end':(5, 19), 'text':'which colocalize with eNOS in the Golgi and plasma membrane'}, {'start':(5, 20), 'end':(5, 24), 'text':'and interact with eNOS .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 22), 'text':'Importantly , inhibition of DHHC-21 palmitoyl transferase , but not DHHC-3 , in human endothelial cells reduces eNOS palmitoylation , eNOS targeting ,'}, {'start':(6, 23), 'end':(6, 27), 'text':'and stimulated NO production .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 7), 'text':'Collectively , our data describe five new Golgi'}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 8), 'end':(7, 14), 'text':'targeted DHHC enzymes in human endothelial cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 15), 'end':(7, 21), 'text':'and suggest a regulatory role of DHHC-21'}, {'start':(7, 22), 'end':(7, 28), 'text':'in governing eNOS localization and function .'}]}]}]}]}
123	216	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Materials and methods'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 2), 'text':'Chemicals and antibodies'}, {'start':(2, 0), 'end':(2, 16), 'text':'Mouse monoclonal antibodies against caveolin-1 , GM 130 , and eNOS were provided by BD Biosciences .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 11), 'text':'Rabbit polyclonal antibody anti-beta-COP was purchased from Affinity BioReagents , Inc. .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(4, 0), 'end':(4, 9), 'text':'Mouse monoclonal against beta-actin antibody was provided by Sigma-Aldrich .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 13), 'text':'Rat monoclonal antibody anti-HA high affinity ( 3F10 ) was purchased from Roche .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 14), 'text':'Rabbit polyclonal antibody against phospho-eNOS ( Ser 1179 ) was obtained from Zymed Laboratories .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(7, 0), 'end':(7, 10), 'text':'Goat anti-mouse IRDye 800 conjugated antibody was purchased from Rockland .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 0), 'end':(8, 10), 'text':'Goat anti-rabbit Alexa fluor 680 antibody was provided by Invitrogen ,'}, {'start':(8, 11), 'end':(8, 25), 'text':'and goat anti-rat Texas red dye conjugated antibody was purchased from Jackson ImmunoResearch Laboratories .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 7), 'text':'The chemical products were provided by Sigma-Aldrich .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 1), 'text':'Cell culture'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 20), 'text':'HEK 293 , COS-7 , HASMC , A 459 , LnCap , and EA.hy .926 cells were grown in high-glucose DME'}, {'start':(11, 21), 'end':(11, 23), 'text':'( Invitrogen )'}]}, {'start':(11, 24), 'end':(11, 56), 'text':'supplemented with FBS ( Hyclone ) , penicillin-streptomycin ( Sigma-Aldrich ) , and HAT ( EA.hy .926 only ; Sigma-Aldrich ) at 37degreesC in a humidified atmosphere of 5 % CO 2 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 5), 'text':'HUVECs were grown in EGM-2 media'}, {'start':(12, 6), 'end':(12, 9), 'text':'( Clonetics ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 4), 'text':'Plasmid constructions and cell transfections'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(14, 0), 'end':(14, 0), 'text':'cDNAs'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 1), 'end':(14, 7), 'text':'encoding DHHC proteins were cloned in PEF-Bos-HA'}, {'start':(14, 8), 'end':(14, 11), 'text':'( BD Biosciences )'}]}, {'start':(14, 12), 'end':(14, 17), 'text':'as previously described ( ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(15, 0), 'end':(15, 13), 'text':'WT , C15 and 26S , G2A , and L2S eNOS cDNAs were constructed'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 14), 'end':(15, 21), 'text':'and subcloned into the mammalian expression vector pcDNA3'}, {'start':(15, 22), 'end':(15, 24), 'text':'( Invitrogen )'}]}, {'start':(15, 25), 'end':(15, 30), 'text':'as previously described ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(16, 0), 'end':(16, 11), 'text':'S17 , S25 , S1179A , and S1179D eNOS cDNAs were constructed'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 12), 'end':(16, 16), 'text':'and subcloned in pcDNA3 vector'}, {'start':(16, 17), 'end':(16, 19), 'text':'( Invitrogen )'}]}, {'start':(16, 20), 'end':(16, 23), 'text':'as previously described .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 12), 'text':'The sequences of the PCR fragments cloned were verified by DNA sequencing .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(18, 0), 'end':(18, 18), 'text':'For cell transfection , semiconfluent ( 60 % ) COS-7 and HEK 293 cells were grown in 6-well plates'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 19), 'end':(18, 24), 'text':'and transfected with the different plasmids'}, {'start':(18, 25), 'end':(18, 28), 'text':'using Lipofectamine 2000 .'}]}]}]}]}]}]}, {'start':(19, 0), 'end':(19, 9), 'text':'A beta-gal plasmid was used to normalize DNA quantities .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(20, 0), 'end':(20, 0), 'text':'Immunofluorescence'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(21, 0), 'end':(21, 4), 'text':'COS-7 and EA.hy .926 cells'}, {'label':'joint', 'direction':'None', 'children':[{'start':(21, 5), 'end':(21, 19), 'text':'grown on coverslips were fixed with 4 % PFA for 5 min at room temperature'}, {'start':(21, 20), 'end':(21, 25), 'text':'and rinsed twice with PBS .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 13), 'text':'The cells were then permeabilized with 0.1 % Triton X-100 for 10 min ,'}, {'start':(22, 14), 'end':(22, 18), 'text':'washed twice with PBS ,'}]}, {'start':(22, 19), 'end':(22, 39), 'text':'and incubated with blocking solution ( 5 % normal goat serum in PBS ) for 45 min at room temperature .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 9), 'text':'Next , the cells were incubated with the primary antibodies'}, {'start':(23, 10), 'end':(23, 13), 'text':'( diluted 1:500 )'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(23, 14), 'end':(23, 16), 'text':'overnight at 4degreesC'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 17), 'end':(23, 23), 'text':'and washed twice with blocking solution ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 24), 'end':(23, 30), 'text':'followed by a 45-min incubation with fluorophore'}, {'start':(23, 31), 'end':(23, 38), 'text':'conjugated secondary antibody ( FITC or TRITC ;'}]}, {'start':(23, 39), 'end':(23, 45), 'text':'diluted 1:250 ) at room temperature .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(24, 0), 'end':(24, 14), 'text':'The coverslips were then mounted on glass slides with Gelvatol and DAPI ( Sigma-Aldrich )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 15), 'end':(24, 20), 'text':'and analyzed with an epifluorescence microscope'}, {'start':(24, 21), 'end':(24, 34), 'text':'( Axiovert ; Carl Zeiss MicroImaging , Inc. ) with a 63x objective .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 5), 'text':'Images were acquired using a charge'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 6), 'end':(25, 8), 'text':'coupled device camera'}, {'start':(25, 9), 'end':(25, 18), 'text':'( Axio ; Carl Zeiss MicroImaging , Inc. ) .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 8), 'text':'Analysis of different images was performed using Openlab software'}, {'start':(26, 9), 'end':(26, 11), 'text':'( Improvision )'}]}, {'start':(26, 12), 'end':(26, 15), 'text':'after subtracting background .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 2), 'text':'NO release analysis'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(28, 0), 'end':(28, 12), 'text':'48 h after transfection of eNOS and DHHC plasmids into COS-7 cells ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(28, 13), 'end':(28, 16), 'text':'the media was removed'}, {'start':(28, 17), 'end':(28, 28), 'text':'and the cells were supplemented with serum-free DME for 24 h .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 23), 'text':'The media was then processed for the measurement of nitrite ( NO 2 - ) by a NO specific chemiluminescence analyzer ( Sievers )'}, {'start':(29, 24), 'end':(29, 29), 'text':'as described previously ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 13), 'text':'The same cells were then incubated with fresh , serum-free DME for 30 min'}, {'start':(30, 14), 'end':(30, 20), 'text':'to calculate the preagonist nitrite accumulation .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(31, 0), 'end':(31, 13), 'text':'Subsequently , the cells were incubated with 1 muM ionomicin for another 30 min'}, {'start':(31, 14), 'end':(31, 19), 'text':'to allow postagonist nitrite accumulation .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(32, 0), 'end':(32, 5), 'text':'The medium was then harvested ,'}, {'start':(32, 6), 'end':(32, 11), 'text':'and nitrite accumulation was measured .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(33, 0), 'end':(33, 17), 'text':'In other experiments , DHHC-21 and -3 were silenced after treatment with specific siRNAs for 48 h ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(33, 18), 'end':(33, 25), 'text':'and EA.hy .926 cells were analyzed for basal'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 26), 'end':(33, 29), 'text':'and stimulated NO release'}, {'start':(33, 30), 'end':(33, 32), 'text':'as described .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 1), 'text':'Sucrose gradient'}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(35, 0), 'end':(35, 11), 'text':'Transfected COS-7 cells ( 150-mm dish ) were washed twice with PBS'}, {'start':(35, 12), 'end':(35, 26), 'text':'and scrapped into 2 ml of ice-cold 500 mM sodium carbonate , pH 11 ,'}]}, {'start':(35, 27), 'end':(35, 39), 'text':'supplemented with 1 mg and ml protease inhibitor cocktail ( Roche ) ,'}]}, {'start':(35, 40), 'end':(35, 42), 'text':'Dounce homogenized ,'}]}, {'start':(35, 43), 'end':(35, 56), 'text':'and sonicated ( three 20-s bursts at 30 % of maximal power ) .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 17), 'text':'The homogenate was then adjusted to 42.5 % sucrose by the addition of 2 ml 85 % sucrose'}, {'start':(36, 18), 'end':(36, 20), 'text':'prepared in MBS'}]}, {'start':(36, 21), 'end':(36, 33), 'text':'( 25 mM MES , pH 6.5 , and 0.5 M NaCl )'}]}, {'start':(36, 34), 'end':(36, 43), 'text':'and placed at the bottom of an ultracentrifuge tube .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(37, 0), 'end':(37, 31), 'text':'A 5-30 % discontinuous sucrose gradient was formed ( 3 ml of 5 % sucrose and 5 ml of 30 % sucrose , both in MES containing 250 mM sodium carbonate )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 32), 'end':(37, 42), 'text':'and centrifuged at 35,000 rpm for 18 h in a rotor'}, {'start':(37, 43), 'end':(37, 49), 'text':'( SW40 ; Beckman Coulter ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(38, 0), 'end':(38, 14), 'text':'Gradient fractions ( 1 ml ) were collected from the top of the tube ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 15), 'end':(38, 29), 'text':'and 50 mul of each fraction ( 1-12 ) was used for Western blotting analysis'}, {'start':(38, 30), 'end':(38, 35), 'text':'as described previously ( ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(39, 0), 'end':(39, 11), 'text':'The percentage of total proteins in different fractions was determined by densitometry'}, {'start':(39, 12), 'end':(39, 23), 'text':'and plotted as percentage of total protein ( NIH program ) .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 2), 'text':'Immunoprecipitation and immunoblotting'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 9), 'text':'EA.hy .926 and COS-7 cells were lysed in ice-cold buffer'}, {'start':(41, 10), 'end':(41, 51), 'text':'containing 50 mM Tris-HCl , pH 7.5 , 10 % glycerol , 125 mM NaCl , 1 % NP-40 , 5.3 mM NaF , 1.5 mM NaP , 1mM orthovanadate , 1 mg and ml protease inhibitor cocktail ( Roche ) ,'}]}, {'start':(41, 52), 'end':(41, 61), 'text':'and 0.25 mg and ml AEBSF ( Roche ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 8), 'text':'Cell lysates were rotated at 4degreesC for 30 min'}, {'start':(42, 9), 'end':(42, 23), 'text':'before the insoluble material was removed by centrifugation at 12,000 g for 10 min .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(43, 0), 'end':(43, 6), 'text':'After normalizing for equal protein concentration ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 7), 'end':(43, 19), 'text':'lysates were precleared by incubation with protein G-agarose for 45 min at 4degreesC'}, {'start':(43, 20), 'end':(43, 22), 'text':'with rocking .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(44, 0), 'end':(44, 10), 'text':'Precleared samples were then immunoprecipitated with anti-HA and anti-eNOS antibodies .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(45, 0), 'end':(45, 18), 'text':'Proteins in both the cell lysates and immunoprecipitates were heated in SDS sample buffer before separation by SDS-PAGE .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 16), 'text':'After overnight transfer of the proteins onto nitrocellulose membranes , Western blots were performed using the antibodies'}, {'start':(46, 17), 'end':(46, 25), 'text':'described above ( see Chemicals and antibodies ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 1), 'text':'Palmitate labeling'}, {'start':(48, 0), 'end':(48, 24), 'text':'Transfected HEK 293 cells were preincubated for 30 min in serum-free DME with 10 mg and ml of fatty acid-free BSA ( Sigma-Aldrich ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(49, 0), 'end':(49, 26), 'text':'Cells were then labeled with 0.5 mCi and ml 3 [ H ] - palmitic acid ( PerkinElmer ) for 4 h in the preincubation medium .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 5), 'text':'Cells were washed with PBS ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(50, 6), 'end':(50, 37), 'text':'scraped with SDS-PAGE sample buffer ( 62.5 mM Tris-HCl , pH 6.8 , 10 % glycerol , 2 % SDS , 0,001 % bromophenol blue , and 10 mM DTT ) ,'}, {'start':(50, 38), 'end':(50, 43), 'text':'and boiled for 2 min .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(51, 0), 'end':(51, 62), 'text':'In other experiments , EA.hy .926 cells were solubilized by incubation in 1 ml of lysis buffer containing 50 mM Tris-HCl , pH 7.5 , 10 % glycerol , 125 mM NaCl , 1 % NP-40 , 5.3 mM NaF , 1.5 mM NaP , 1 mM orthovanadate , 1 mg and ml protease inhibitor cocktail , and 0.25 mg and ml AEBSF'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 63), 'end':(51, 67), 'text':'and subjected to eNOS immunoprecipitation'}, {'start':(51, 68), 'end':(51, 77), 'text':'as described above ( see Immunoprecipitation and immunoblotting ) .'}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 9), 'text':'For fluorography , protein samples were separated by SDS-PAGE .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 12), 'text':'Gels were treated with Amplify ( GE Healthcare ) for 30 min ,'}, {'start':(53, 13), 'end':(53, 16), 'text':'dried under vacuum ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 17), 'end':(53, 21), 'text':'and exposed to a film'}, {'start':(53, 22), 'end':(53, 28), 'text':'( Biomax MS ; Kodak ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 5), 'text':'Autoradiographs were scanned with a scanner'}, {'start':(54, 6), 'end':(54, 8), 'text':'( Canon )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 9), 'end':(54, 14), 'text':'and quantified using the IMAGE J'}, {'start':(54, 15), 'end':(54, 19), 'text':'( NIH ) program .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 0), 'end':(55, 1), 'text':'siRNA treatment'}, {'start':(56, 0), 'end':(56, 8), 'text':'DHHC-21 ( available from GenBank/EMBL/DDBJ under accession no .'}]}]}]}, {'start':(57, 0), 'end':(57, 8), 'text':'NM_178566 ) DNA and DHHC-3 ( accession no .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 7), 'text':'NM_016598 ) target sequences were designed by QIAGEN'}, {'start':(58, 8), 'end':(58, 13), 'text':'( HP guaranteed siRNA ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(59, 0), 'end':(59, 19), 'text':'In all experiments , we used the same concentration of each of the four siRNAs ( 12.5 nM ) .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(60, 0), 'end':(60, 32), 'text':'The target sequences for DHHC-21 were 5 \' - CAGGCAGTTATAAGATTGCAA-3 \' ( siRNA-1 ) , 5 \' - CTAGTATAACTAGATAGTATA-3 \' ( siRNA-2 ) , 5 \' - TAGCTAGTGTTAGGAAGTGAA-3 \' ( siRNA-3 ) ,'}, {'start':(60, 33), 'end':(60, 42), 'text':'and 5 \' - CACCTTCTTATAGTATAGGTA-3 \' ( siRNA-4 ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(61, 0), 'end':(61, 31), 'text':'The target sequences for DHHC-3 were 5 \' - ACGGGAATAGAACAATTGAAA-3 \' ( siRNA-1 ) , 5 \' AACATTGAGCGGAAACCAGAA-3 \' ( siRNA-2 ) , 5 \' - AAAGGAAATGCCACTAAAGAA-3 \' ( siRNA-3 ) ,'}, {'start':(61, 32), 'end':(61, 40), 'text':'and 5 \' - CTACGTGTATAGCATCATCAA ( siRNA-4 ) .'}]}]}, {'start':(62, 0), 'end':(62, 10), 'text':'Our nonsilencing DNA target was 5 \' - AATTCTCCGAACGTGTCACGT-3 \' .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(63, 0), 'end':(63, 3), 'text':'siRNA duplexes were formed'}, {'start':(63, 4), 'end':(63, 10), 'text':'according to the manufacturer \'s protocol .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(64, 0), 'end':(64, 17), 'text':'For cell transfection , EA.hy .926 cells were grown to 30 % of confluence in 6-well plates .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(65, 0), 'end':(65, 22), 'text':'150 mul of Opti-MEM-1 medium ( Invitrogen ) was incubated for 5 min with siRNA sequences ( 50 nM final concentration ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(66, 0), 'end':(66, 20), 'text':'In addition , 150 mul of Opti-MEM-1 was incubated with 5 mul of Oligofectamine ( Invitrogen ) for 5 min .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(67, 0), 'end':(67, 4), 'text':'The two solutions were combined'}, {'label':'joint', 'direction':'None', 'children':[{'start':(67, 5), 'end':(67, 12), 'text':'and incubated at room temperature for 30 min'}, {'start':(67, 13), 'end':(67, 28), 'text':'and then added to cells ( 1.5 ml of total volume ) for 6 h .'}]}]}]}, {'start':(68, 0), 'end':(68, 17), 'text':'After transfection , cells were supplemented with 1.5 ml of DME with 10 % FBS and antibiotics .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(69, 0), 'end':(69, 4), 'text':'RT-PCR and quantitative real-time PCR'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(70, 0), 'end':(70, 6), 'text':'Total RNA was extracted with Trizol reagent'}, {'start':(70, 7), 'end':(70, 10), 'text':'( Invitrogen ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 0), 'end':(71, 5), 'text':'cDNA was synthesized from 5 mug'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(71, 6), 'end':(71, 12), 'text':'using SuperScript first-strand synthesis system for RT-PCR'}, {'start':(71, 13), 'end':(71, 16), 'text':'( Invitrogen ) .'}]}]}, {'start':(72, 0), 'end':(72, 18), 'text':'A 1-mul aliquot of the reverse transcription reaction was then used for subsequent PCR amplification with specific primers .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(73, 0), 'end':(73, 31), 'text':'Each 25-mul PCR contained 1 mul of the reverse transcription reaction , 1 mM dNTPs ( Roche ) , 20 pmol of each primer , and 1.25 U of Taq DNA polymerase'}, {'start':(73, 32), 'end':(73, 35), 'text':'( QIAGEN ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(74, 0), 'end':(74, 7), 'text':'The primers sequences used were as follows :'}, {'start':(74, 8), 'end':(74, 16), 'text':'GAPDH ( available from GenBank/EMBL/DDBJ under accession no .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(75, 0), 'end':(75, 19), 'text':'BC_013310 ) , 5 \' - CCACCCATGGCCAAATTCCATGGCA-3 \' and 5 \' - TCTAGACGGCAGGTCAGGTCCACC-3 \' ; DHHC-2 ( accession no .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(76, 0), 'end':(76, 19), 'text':'NM_016353 ) , 5 \' - CGCCATCCAGCTGTGCATAGTG-3 \' and 5 \' - GAGCAGTGATGGCAGCGATCTG-3 \' ; DHHC-3 ( accession no .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(77, 0), 'end':(77, 19), 'text':'NM_016598 ) , 5 \' - TGTTTGTAAGCGGTGCATTCGG-3 \' and 5 \' - TTGGTCTGGCGTGGCAAAGG-3 \' ; DHHC-7 ( accession no .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(78, 0), 'end':(78, 19), 'text':'NM_017740 ) , 5 \' - TGCGATGGGAAGGGATGAAGTC-3 \' and 5 \' - GGCGTTTGGCTTCTTCGTGTG-3 \' ; DHHC-8 ( accession no .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(79, 0), 'end':(79, 14), 'text':'NM_013373 ) , 5 \' - TCAAACCCGCCAAGTACATCCC-3 \' and 5 \' - ACGCCCGATGCAGTTGTTGAC-3 \' ;'}, {'start':(79, 15), 'end':(79, 20), 'text':'and DHHC-21 ( accession no .'}]}]}]}]}]}]}]}]}]}]}, {'start':(80, 0), 'end':(80, 13), 'text':'NM_178566 ) 5 \' - AAGCGTTCCCATCACTGCAGC-3 \' and 5 \' - GAACTCGCAGTGGTTGCCTCTG-3 \' .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(81, 0), 'end':(81, 29), 'text':'Each cycle of PCR consisted of denaturation at 90degreesC for 1 min , primer annealing at 60degreesC for 1 min , and primer extension at 72degreesC for 2 min .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(82, 0), 'end':(82, 9), 'text':'PCR products were separated on a 2 % agarose gel'}, {'start':(82, 10), 'end':(82, 15), 'text':'and stained with ethidium bromide .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(83, 0), 'end':(83, 15), 'text':'Quantitative real-time PCR was performed by using iQ SYBR green supermix on iCycler real-time detection system'}, {'start':(83, 16), 'end':(83, 20), 'text':'( Bio-Rad Laboratories ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(84, 0), 'end':(84, 1), 'text':'Statistical analysis'}, {'start':(85, 0), 'end':(85, 9), 'text':'The results are expressed as mean + /- SD .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(86, 0), 'end':(86, 10), 'text':'Statistical comparisons between groups were done by the t test ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(86, 11), 'end':(86, 16), 'text':'using the Statgraphics Plus 5.0 program'}, {'start':(86, 17), 'end':(86, 22), 'text':'( Statistical Graphics Corp. ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(87, 0), 'end':(87, 2), 'text':'Online supplemental material'}, {'start':(88, 0), 'end':(88, 1), 'text':'Fig .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(89, 0), 'end':(89, 23), 'text':'S1 shows the colocalization between DHHC-CRD enzymes ( DHHC-2 , -3 , -7 , and -8 ) and GM-130 , a Golgi marker .'}, {'start':(90, 0), 'end':(90, 1), 'text':'Fig .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(91, 0), 'end':(91, 9), 'text':'S2 demonstrates the colocalization between eNOS and different acyl transferases'}, {'start':(91, 10), 'end':(91, 20), 'text':'( DHHC-2 , -3 , -7 , and -8 ) .'}]}, {'start':(92, 0), 'end':(92, 7), 'text':'Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200601051/DC1 .'}]}]}]}]}]}]}]}]}]}
217	218	{'start':(0, 0), 'end':(0, 4), 'text':'[ Supplemental Material Index ]'}
97	123	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Discussion'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 13), 'text':'The most salient feature of this paper is the identification of five DHHC-PAT cDNAs'}, {'start':(1, 14), 'end':(1, 27), 'text':'that can palmitoylate the dually acylated , peripheral membrane protein eNOS in vivo .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 24), 'text':'DHHC-2 , -3 , -7 , -8 , and -21 colocalize with GM-130 , a peripheral membrane protein of the Golgi in transfected cells ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(2, 25), 'end':(2, 25), 'text':'suggesting'}, {'start':(2, 26), 'end':(2, 38), 'text':'that palmitoylation can occur on the cytoplasmic aspect of the Golgi complex .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 9), 'text':'The aforementioned DHHC-PATs also colocalize and associate with eNOS ,'}, {'start':(3, 10), 'end':(3, 18), 'text':'providing evidence for the compartmentalization of protein palmitoylation .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 2), 'text':'Most critical ,'}, {'start':(4, 3), 'end':(4, 12), 'text':'reduction of DHHC-21 in endothelial cells diminishes eNOS palmitoylation ,'}]}, {'start':(4, 13), 'end':(4, 15), 'text':'mislocalizes eNOS ,'}]}, {'start':(4, 16), 'end':(4, 22), 'text':'and impairs agonist stimulated NO release .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(5, 0), 'end':(5, 14), 'text':'Although cysteine palmitoylation has long been recognized as important for protein trafficking and function ,'}, {'start':(5, 15), 'end':(5, 22), 'text':'enzymes responsible for this have been elusive .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(6, 0), 'end':(6, 7), 'text':'Genetic and biochemical studies in yeast initially identified'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 8), 'end':(6, 10), 'text':'that two genes'}, {'start':(6, 11), 'end':(6, 12), 'text':'containing CRDs'}]}, {'start':(6, 13), 'end':(6, 22), 'text':'are essential for palmitoylation of Ras2 and casein kinase .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 15), 'text':'This led to the discovery of mammalian DHHC genes and identification of their specific substrates .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 6), 'text':'Out of the 23 independent mammalian genes'}, {'start':(8, 7), 'end':(8, 11), 'text':'encoding DHHC containing proteins ,'}]}, {'start':(8, 12), 'end':(8, 20), 'text':'only a few enzyme substrates have been identified .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 10), 'text':'DHHC-2 , -3 , -7 , and -15 can palmitoylate PSD-95'}, {'start':(9, 11), 'end':(9, 18), 'text':'( ) , DHHC-3 ( GODZ ; )'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 19), 'end':(9, 23), 'text':'can palmitoylate the GABA-A receptor'}, {'start':(9, 24), 'end':(9, 33), 'text':'( ) , DHHC-17 can palmitoylate several neuronal substrates ,'}]}]}, {'start':(9, 34), 'end':(9, 40), 'text':'including SNAP-25 and PSD-95 ( ) ,'}]}, {'start':(9, 41), 'end':(9, 50), 'text':'and DHHC-9 can palmitoylate H- and N-Ras ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 24), 'text':'In the present study , only DHHC-2 , -3 , -7 , -8 , and -21 significantly increased the incorporation of palmitate into eNOS ,'}, {'start':(10, 25), 'end':(10, 34), 'text':'suggesting some degree of substrate specificity of the DHHCs .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(11, 0), 'end':(11, 15), 'text':'As DHHC-2 , -3 , and -7 can palmitoylate the nonmyristoylated proteins PSD95 and GalphaS ,'}, {'start':(11, 16), 'end':(11, 28), 'text':'these candidates are less likely to be specific N-myristoyl-requiring PATs ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 9), 'text':'RNAi mediated knockdown of endogenous DHHC-21 in endothelial cells reduces'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(12, 10), 'end':(12, 21), 'text':'the incorporation of 3 [ H ] - palmitate into eNOS ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(12, 22), 'end':(12, 24), 'text':'mislocalizes eNOS ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 25), 'end':(12, 31), 'text':'and reduces agonist stimulated NO release ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 32), 'end':(12, 42), 'text':'whereas knock down of DHHC-3 did not reduce NO release ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(12, 43), 'end':(12, 43), 'text':'suggesting'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(12, 44), 'end':(12, 57), 'text':'that although at least five DHHCs can significantly palmitoylate eNOS in transfected cells ,'}, {'start':(12, 58), 'end':(12, 66), 'text':'DHHC-21 may be a more specific eNOS PAT .'}]}]}]}]}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 16), 'text':'The reasons for the apparent specificity of DHHC-21 toward eNOS in endothelial cells are not known ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 17), 'end':(13, 31), 'text':'but it may be due to the amount of DHHC-21 protein relative to other DHHCs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 32), 'end':(13, 42), 'text':'expressed in endothelial cells or to the posttranslational modification of DHHCs'}, {'start':(13, 43), 'end':(13, 58), 'text':'that may determine its substrate specificity or regulate its activity in a cell specific context .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 8), 'text':'In addition , we can not rule the possibility'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'start':(14, 9), 'end':(14, 17), 'text':'that other DHHCs palmitoylate eNOS in endothelial cells ,'}, {'start':(14, 18), 'end':(14, 37), 'text':'as a substantial knock down of DHHC-21 reduced palmitoylation by only 50 % and NO release by 70 % .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 1), 'text':'Additional experiments'}, {'start':(15, 2), 'end':(15, 12), 'text':'using isoform selective antibodies and recombinant DHHC proteins with various substrates'}]}, {'start':(15, 13), 'end':(15, 24), 'text':'will help deconvolve DHHC substrate specificity and kinetics in more detail .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 3), 'text':'Other interesting findings are'}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 4), 'end':(16, 22), 'text':'that DHHC-2 , -3 , -7 , -8 , and -21 all enhance the transfer of palmitate into eNOS'}, {'start':(16, 23), 'end':(16, 29), 'text':'and are strongly colocalized with GM130 ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 30), 'end':(16, 47), 'text':'a Golgi matrix protein localized to the cytoplasmic face of the Golgi , consistent with our previous suggestion'}, {'start':(16, 48), 'end':(16, 59), 'text':'that the Golgi is the site for eNOS palmitoylation ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 30), 'text':'Palmitoylation of substrates on the Golgi would stabilize protein association via kinetic trapping ( ) and allow for protein localization either on the Golgi or movement to the plasma membrane ,'}, {'start':(17, 31), 'end':(17, 38), 'text':'as recently confirmed for Ras ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 19), 'text':'Supporting this are data showing that DHHC-9 , an H- and N-Ras PAT , colocalizes and interacts with GCP16 ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 20), 'end':(18, 27), 'text':'which is a Golgi localized cosubunit ( )'}, {'start':(18, 28), 'end':(18, 44), 'text':'that appears necessary for DHHC-9 activity toward Ras and movement of Ras to the plasma membrane .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 5), 'text':'For most dually acylated proteins ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 6), 'end':(19, 11), 'text':'N myristoylation is a cotranslational modification'}, {'start':(19, 12), 'end':(19, 17), 'text':'that favors posttranslational cysteine palmitoylation .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 12), 'text':'For eNOS , mutation of the palmitoylation sites does not affect N myristoylation'}, {'start':(20, 13), 'end':(20, 28), 'text':'but blocks tight perinuclear targeting and NO release from cells ( , , 1997 ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(21, 0), 'end':(21, 16), 'text':'The mistargeting and dysfunction of these mutants may reflect a structural change or lack of palmitoylation ;'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 17), 'end':(21, 22), 'text':'however , our RNAi experiments ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(21, 23), 'end':(21, 24), 'text':'which show'}, {'label':'joint', 'direction':'None', 'children':[{'start':(21, 25), 'end':(21, 31), 'text':'that reduction in DHHC-21 decreases eNOS palmitoylation'}, {'start':(21, 32), 'end':(21, 35), 'text':'and impairs targeting ,'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 36), 'end':(21, 36), 'text':'indicate'}, {'start':(21, 37), 'end':(21, 48), 'text':'that palmitoylation of eNOS is crucial for proper targeting and function .'}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 13), 'text':'The discovery of DHHC-PATs in vascular cells represents a new , exciting area .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 1), 'text':'Many proteins'}, {'start':(23, 2), 'end':(23, 8), 'text':'involved in signal transduction are palmitoylated ,'}]}, {'start':(23, 9), 'end':(23, 19), 'text':'and this fatty acid modification is often necessary for function .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(24, 0), 'end':(24, 7), 'text':'Understanding the tissue and cellular distribution of DHHCs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 8), 'end':(24, 17), 'text':'and their substrates is critical for identification of PAT inhibitors'}, {'start':(24, 18), 'end':(24, 23), 'text':'that may be therapeutically useful .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 1), 'text':'Our data'}, {'start':(25, 2), 'end':(25, 2), 'text':'showing'}]}, {'start':(25, 3), 'end':(25, 9), 'text':'that DHHC-21 is a major eNOS PAT'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(25, 10), 'end':(25, 10), 'text':'suggests'}, {'start':(25, 11), 'end':(25, 29), 'text':'that antagonizing this enzyme may be useful for reducing NO dependent changes in vascular permeability and tumor angiogenesis .'}]}]}]}]}]}
33	97	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Results'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 4), 'text':'Identification of candidate eNOS PATs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 2), 'text':'Human embryonic kidney'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 3), 'end':(2, 32), 'text':'( HEK ) 293 cells were cotransfected with each of the palmitoyl transferase cDNAs together with eNOS and the biosynthetic incorporation of 3 [ H ] - palmitate into eNOS'}, {'start':(2, 33), 'end':(2, 36), 'text':'examined by fluorography .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 45), 'text':'As shown in , only five clones ( DHHC-2 , -3 , -7 , -8 , and -21 ) markedly enhanced incorporation of 3 [ H ] - palmitate into eNOS ( , top , see fold increase in label relative to total eNOS ) ,'}, {'start':(3, 46), 'end':(3, 52), 'text':'defining them as putative eNOS PATs .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 14), 'text':'The incorporation of palmitate into thioester linkages is sensitive to the strong base hydroxylamine .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 19), 'text':'As shown in , the incorporation of 3 [ H ] - palmitate into eNOS is reduced by hydroxylamine ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(5, 20), 'end':(5, 20), 'text':'demonstrating'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 21), 'end':(5, 36), 'text':'that this occurs via a thioester linkage similar to the palmitoylation of PSD-95 by DHHC-3 ,'}, {'start':(5, 37), 'end':(5, 43), 'text':'which was recently described ( ) .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 18), 'text':'In addition , mutation in the core DHHC domain of these enzymes ( mutation of DHHC to DHHS )'}, {'start':(6, 19), 'end':(6, 38), 'text':'reduces the incorporation of 3 [ H ] - palmitate into eNOS ( ) , consistent with previous reports .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 19), 'text':'Next , we examined the expression of the five candidate eNOS PATs by RT-PCR in different human cell lines ,'}, {'start':(7, 20), 'end':(7, 48), 'text':'including HUVECs , human aortic smooth muscle cells ( HASMCs ) , HEK 293 , lung carcinoma ( A549 ) , and prostate carcinoma cells ( LnCAP ) .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(8, 0), 'end':(8, 3), 'text':'As shown in ,'}, {'start':(8, 4), 'end':(8, 15), 'text':'all of tested DHHCs are expressed in the cell lines studied .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 8), 'text':'However , in HUVEC , the major cell type'}, {'start':(9, 9), 'end':(9, 12), 'text':'that expresses eNOS ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 13), 'end':(9, 19), 'text':'DHHC-21 was the most highly expressed ,'}, {'start':(9, 20), 'end':(9, 25), 'text':'followed by DHHC-2 and -3 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 15), 'text':'Cysteines 15 and 26 have been identified as the major sites of palmitoylation of eNOS .'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(11, 0), 'end':(11, 16), 'text':'As displayed in , transfection of DHHC-21 , but not -11 ( as a control ) ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 17), 'end':(11, 31), 'text':'increases the incorporation of 3 [ H ] - palmitate into eNOS , an effect'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 32), 'end':(11, 41), 'text':'eliminated by mutation of cysteines 15 and 26 to serine'}, {'start':(11, 42), 'end':(11, 48), 'text':'( C15 and 26S eNOS ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 23), 'text':'DHHC-2 , -3 , -7 , -8 , and -21 localize to the Golgi region and plasma membrane in a pattern similar to eNOS'}, {'label':'joint', 'direction':'None', 'children':[{'start':(13, 0), 'end':(13, 9), 'text':'We expressed the HA tagged DHHC proteins in COS-7 cells'}, {'start':(13, 10), 'end':(13, 16), 'text':'and localized them by immunofluorescence microscopy .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 3), 'text':'As shown in ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(14, 4), 'end':(14, 7), 'text':'DHHC-21 ( middle )'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 8), 'end':(14, 14), 'text':'colocalized with the Golgi matrix protein GM-130'}, {'start':(14, 15), 'end':(14, 18), 'text':'( left ) ,'}]}, {'start':(14, 19), 'end':(14, 29), 'text':'as did DHHC-2 , -3 , -7 , and -8 .'}]}]}]}, {'start':(15, 0), 'end':(15, 33), 'text':'Increasing the magnification of these images by 4x ( , bottom ) depicts clear colocalization of DHHC-21 with GM130 and a lesser amount of protein in the plasma membrane ( , arrows ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 12), 'text':'Next , we determined the proportional distribution of these enzymes in sodium carbonate'}, {'start':(16, 13), 'end':(16, 18), 'text':'using a discontinuous sucrose gradient .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 21), 'text':'In this method , tightly embedded membrane proteins are buoyant ( at the 5-30 % sucrose interface in fractions 2-4 ) ,'}, {'start':(17, 22), 'end':(17, 37), 'text':'whereas soluble proteins remain at the bottom of the gradient ( in fractions 7-10 ) .'}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 27), 'text':'In all the gradients , the distribution of caveolin-1 , the coat protein of caveolae , and beta-COP , a marker of Golgi and post-Golgi vesicles were used'}, {'start':(18, 28), 'end':(18, 32), 'text':'to confirm adequate fractionation .'}]}]}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(19, 0), 'end':(19, 3), 'text':'As shown in ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 4), 'end':(19, 14), 'text':'the DHHCs and eNOS cofractionated into two pools , light membranes'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 15), 'end':(19, 20), 'text':'enriched in caveolin-1 and heavy membranes'}, {'start':(19, 21), 'end':(19, 30), 'text':'enriched in beta-COP and beta-actin ( not depicted ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(20, 0), 'end':(20, 9), 'text':'Densitometric quantification ( , right ) of protein localization showed'}, {'start':(20, 10), 'end':(20, 31), 'text':'that a fraction of all DHHCs sediment as integral membrane proteins , with the greatest proportional amount for DHHC-2 and -21 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 7), 'text':'Colocalization and coimmunoprecipitation of DHHC enzymes with eNOS'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 12), 'text':'Next , we examined colocalization of eNOS with DHHC enzymes by immunofluorescence microscopy'}, {'start':(22, 13), 'end':(22, 16), 'text':'in transfected cells .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(23, 0), 'end':(23, 8), 'text':'COS-7 cells were cotransfected with the cDNAs for eNOS'}, {'start':(23, 9), 'end':(23, 23), 'text':'and HA tagged DHHC-21 and localized with antibodies against eNOS and the HA epitope .'}]}, {'start':(24, 0), 'end':(24, 14), 'text':'As shown in , eNOS and DHHC-21 ( other DHHCs are shown in Fig .'}]}]}, {'start':(25, 0), 'end':(25, 19), 'text':'S2 , available at http://www.jcb.org/cgi/content/full/jcb.200601051/DC1 ) colocalized in the Golgi region and to a lesser extent in plasma membrane .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(26, 0), 'end':(26, 13), 'text':'Because palmitoylation is a cytoplasmic event and eNOS is a peripheral membrane protein ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(26, 14), 'end':(26, 15), 'text':'we determined'}, {'start':(26, 16), 'end':(26, 23), 'text':'whether DHHC enzymes and eNOS can interact .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(27, 0), 'end':(27, 6), 'text':'As seen in ( left ) ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 7), 'end':(27, 8), 'text':'the HA'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 9), 'end':(27, 19), 'text':'tagged DHHCs and eNOS were well expressed in total cell lysates'}, {'start':(27, 20), 'end':(27, 24), 'text':'prepared from the cells .'}]}]}]}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 5), 'text':'Immunoprecipitation of HA tagged DHHC enzymes'}, {'start':(28, 6), 'end':(28, 28), 'text':'using an anti-HA monoclonal antibody detected the coassociation with eNOS ( , right , third to seventh lanes ) with the DHHCs ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 29), 'end':(28, 40), 'text':'whereas no immunoreactive protein was observed after immunoprecipitation of lysates from cells'}, {'start':(28, 41), 'end':(28, 51), 'text':'expressing eNOS alone ( , right , first lane ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 11), 'text':'Previously , we targeted eNOS to the Golgi versus the plasma membrane'}, {'start':(29, 12), 'end':(29, 17), 'text':'using different domains of syntaxin-3 .'}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(30, 0), 'end':(30, 14), 'text':'To determine the importance of localization on the interaction between eNOS and DHHC enzymes ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 15), 'end':(30, 17), 'text':'we cotransfected Golgi'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 18), 'end':(30, 26), 'text':'targeted eNOS ( eNOS S17 ) or plasma membrane'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 27), 'end':(30, 28), 'text':'targeted eNOS'}, {'start':(30, 29), 'end':(30, 40), 'text':'( eNOS S25 ) and DHHC-3 , -7 , and -21 .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(31, 0), 'end':(31, 3), 'text':'As shown in ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 4), 'end':(31, 20), 'text':'the interaction between the Golgi targeted eNOS and the DHHC enzymes was stronger than the plasma membrane'}, {'start':(31, 21), 'end':(31, 41), 'text':'targeted isoform , consistent with the majority of DHHCs and eNOS present on the Golgi of transfected cells ( ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(32, 0), 'end':(32, 3), 'text':'Next , we assessed'}, {'start':(32, 4), 'end':(32, 16), 'text':'whether the phosphorylation state could affect the interaction of eNOS with DHHCs .'}]}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(33, 0), 'end':(33, 4), 'text':'To address this question ,'}, {'start':(33, 5), 'end':(33, 23), 'text':'DHHCs were cotransfected with wild-type ( WT ) eNOS and two eNOS phosphomutants , eNOS S1179A and S1179D .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 10), 'text':'Serine 1179 is a key phosphorylation site for several kinases ,'}, {'start':(34, 11), 'end':(34, 23), 'text':'including Akt , AMP kinase , and cAMP protein kinase ( ) ,'}]}, {'start':(34, 24), 'end':(34, 34), 'text':'and phosphorylation of this site is associated with eNOS activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 9), 'text':'Mutation of S1179 to D renders eNOS constitutively active ,'}, {'start':(35, 10), 'end':(35, 17), 'text':'whereas S1179 to A is less activated .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(36, 0), 'end':(36, 7), 'text':'As seen in , in all cases ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 8), 'end':(36, 16), 'text':'WT and phosphomutants were associated with DHHC enzymes ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(36, 17), 'end':(36, 17), 'text':'indicating'}, {'start':(36, 18), 'end':(36, 36), 'text':'that phosphorylation of this particular residue was not critical for the interaction of eNOS with DHHC-3 and -21 .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(37, 0), 'end':(37, 14), 'text':'eNOS fatty acylation is required for an efficient interaction with DHHC proteins and NO release'}, {'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(38, 0), 'end':(38, 16), 'text':'To examine whether the localization of eNOS is important for the interaction of eNOS with DHHCs ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 17), 'end':(38, 27), 'text':'COS cells were transfected with WT and different mutants of eNOS'}, {'start':(38, 28), 'end':(38, 36), 'text':'that influence eNOS acylation and targeting ( ) .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(39, 0), 'end':(39, 19), 'text':'Cells were transfected with WT eNOS ( N myristoylated and S palmitoylated , Golgi , and plasmalemma targeted ) ,'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 20), 'end':(39, 38), 'text':'G2A eNOS ( neither N myristoylated nor S palmitoylated and cytosolic ) , C15 and 26S eNOS ( N'}, {'start':(39, 39), 'end':(39, 58), 'text':'myristoylated but not S palmitoylated ; diffuse perinuclear localization ) , or L2S eNOS ( N myristoylated but not palmitoylated'}]}, {'start':(39, 59), 'end':(39, 86), 'text':'because of the mutation of the intervening leucines between the two palmitoylation sites , C15 and C26 ; diffuse perinuclear pattern ; , ; ) with DHHC-3-HA .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(40, 0), 'end':(40, 6), 'text':'As shown in ( left ) ,'}, {'label':'joint', 'direction':'None', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(40, 7), 'end':(40, 12), 'text':'WT eNOS is primarily Golgi targeted'}, {'start':(40, 13), 'end':(40, 22), 'text':'and G2A eNOS is diffusely distributed throughout the cells ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 23), 'end':(40, 41), 'text':'whereas the palmitoylation deficient mutants , C15 and 26S and L2S eNOS , were retained in the perinuclear region'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(40, 42), 'end':(40, 46), 'text':'but are more diffusely distributed'}, {'start':(40, 47), 'end':(40, 51), 'text':'compared with WT eNOS .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(41, 0), 'end':(41, 3), 'text':'WT eNOS clearly colocalized'}, {'label':'joint', 'direction':'None', 'children':[{'start':(41, 4), 'end':(41, 8), 'text':'with HA tagged DHHC-3 ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(41, 9), 'end':(41, 14), 'text':'whereas G2A eNOS did not ,'}, {'start':(41, 15), 'end':(41, 33), 'text':'and the palmitoylation mutants ( C15 and 26S and L2S eNOS ) had a partially overlapping perinuclear pattern .'}]}]}]}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 5), 'text':'Next , we performed coimmunoprecipitation experiments'}, {'start':(42, 6), 'end':(42, 22), 'text':'to determine the role of acylation and subcellular localization on the coassociation of eNOS with DHHC .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(43, 0), 'end':(43, 24), 'text':'The eNOS constructs and DHHC-3 or -21 were equally expressed based on Western blotting of the proteins in cell lysates ( , left ) ,'}, {'start':(43, 25), 'end':(43, 41), 'text':'and immunoprecipitation of DHHC-3-HA resulted in ample recovery ( , middle ) of DHHC-3 and -21 .'}]}]}, {'start':(44, 0), 'end':(44, 27), 'text':'Interestingly , immunoprecipitation of DHHC-3 and -21 resulted in the coassociation with WT eNOS but not with the other acylation defective eNOS mutants ( , right ) .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(45, 0), 'end':(45, 2), 'text':'These results indicate'}, {'start':(45, 3), 'end':(45, 19), 'text':'that the fatty acylation and targeting are important for the interaction between eNOS and the DHHC-PATs .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(46, 0), 'end':(46, 3), 'text':'Finally , we examined'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(46, 4), 'end':(46, 10), 'text':'whether the DHHCs can influence eNOS function'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(46, 11), 'end':(46, 14), 'text':'by measuring NO release'}, {'start':(46, 15), 'end':(46, 24), 'text':'( as nitrite after 24 h of accumulation ) .'}]}]}]}]}]}]}]}]}]}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(47, 0), 'end':(47, 27), 'text':'Cotransfection of COS-7 cells with WT eNOS and DHHC-3 , -7 , and -21 increased the basal accumulation of NO 2 - into the media ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 0), 'end':(48, 7), 'text':'However , this effect was eliminated in cells'}, {'start':(48, 8), 'end':(48, 20), 'text':'cotransfected with acylation defective G2A or C15 and 26S eNOS ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 23), 'text':'Knock down of endogenous DHHC-21 , but not -3 , levels in endothelial cells impairs eNOS palmitoylation , cellular targeting , and NO release'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(50, 0), 'end':(50, 7), 'text':'Although several DHHC enzymes can palmitoylate eNOS ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(50, 8), 'end':(50, 18), 'text':'DHHC-21 mRNA was the most highly expressed in endothelial cells ,'}, {'label':'joint', 'direction':'None', 'children':[{'start':(50, 19), 'end':(50, 25), 'text':'and the protein localized on the Golgi'}, {'start':(50, 26), 'end':(50, 30), 'text':'and interacted with eNOS .'}]}]}]}]}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(51, 0), 'end':(51, 12), 'text':'To determine the role of DHHC-21 in palmitoylating eNOS in endothelial cells ,'}, {'start':(51, 13), 'end':(51, 18), 'text':'an RNAi approach was used .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(52, 0), 'end':(52, 17), 'text':'As shown in , transfection of endothelial cells with DHHC-21 siRNA duplex RNAs ( at 12.5 nM )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 18), 'end':(52, 41), 'text':'reduced the expression of DHHC-21 ( via quantitative RT-PCR ) expression in a time dependent manner , with maximal reduction at 48 h ,'}, {'start':(52, 42), 'end':(52, 50), 'text':'where nonsilencing RNA as a control was ineffective .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 29), 'text':'The reduction in DHHC-21 mRNA levels resulted in a marked diminution in the incorporation of 3 [ H ] - palmitate into eNOS by ~ 60 % ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(54, 0), 'end':(54, 14), 'text':'Because eNOS palmitoylation is crucial for the perinuclear targeting of eNOS onto the Golgi ,'}, {'start':(54, 15), 'end':(54, 26), 'text':'we performed an immunofluorescence analysis of eNOS in DHHC-21-depleted endothelial cells .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(55, 0), 'end':(55, 6), 'text':'As shown in ( middle ) ,'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(55, 7), 'end':(55, 21), 'text':'knock down of DHHC-21 resulted in a more diffuse , perinuclear pattern of eNOS immunoreactivity'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 22), 'end':(55, 24), 'text':'compared with cells'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 25), 'end':(55, 28), 'text':'treated with nonsilencing RNA'}, {'start':(55, 29), 'end':(55, 32), 'text':'( left ) .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 11), 'text':'In addition , treatment of endothelial cells with 2-bromopalmitate , a substrate'}, {'start':(56, 12), 'end':(56, 16), 'text':'based inhibitor of palmitoylation ,'}]}, {'start':(56, 17), 'end':(56, 31), 'text':'resulted in a similar but more extensive mislocalization of eNOS ( , right ) .'}]}, {'start':(57, 0), 'end':(57, 18), 'text':'We next examined the effect of DHHC-21 knockdown on basal and agonist stimulated NO release from endothelial cells .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 7), 'text':'In endothelial cells , increases in cytoplasmic calcium'}, {'start':(58, 8), 'end':(58, 10), 'text':'activate calmodulin ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(58, 11), 'end':(58, 20), 'text':'which binds to the canonical CaM binding domain in eNOS'}, {'start':(58, 21), 'end':(58, 32), 'text':'and serves as an allosteric regulator of electron flux through eNOS ,'}]}]}, {'start':(58, 33), 'end':(58, 40), 'text':'leading to a burst of NO release .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(59, 0), 'end':(59, 10), 'text':'Reduction of DHHC-21 , but not treatment with nonsilencing RNA ,'}, {'start':(59, 11), 'end':(59, 29), 'text':'caused a slight decrease the basal accumulation of NO 2 - into the media ( , left ) .'}]}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 0), 'end':(60, 12), 'text':'More important , reduction in DHHC-21 reduced the release of NO 2 -'}, {'start':(60, 13), 'end':(60, 25), 'text':'stimulated by both ionomycin ( middle ) and ATP ( right ) ,'}]}, {'start':(60, 26), 'end':(60, 37), 'text':'indicating the importance of eNOS palmitoylation via DHHC-21 for eNOS activation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'RightToLeft', 'children':[{'start':(61, 0), 'end':(61, 10), 'text':'To examine the specificity of DHHC-21 knockdown on eNOS function ,'}, {'start':(61, 11), 'end':(61, 20), 'text':'we also reduced the levels of DHHC-3 with RNAi .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(62, 0), 'end':(62, 15), 'text':'As seen in , transfection of endothelial cells with DHHC-3 siRNA ( at 12.5 nM )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 16), 'end':(62, 25), 'text':'reduced the expression of DHHC-3 ( via quantitative RT-PCR )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(62, 26), 'end':(62, 26), 'text':'expression'}, {'start':(62, 27), 'end':(62, 35), 'text':'where nonsilencing RNA as a control was ineffective .'}]}]}]}, {'start':(63, 0), 'end':(63, 18), 'text':'However , under these conditions , basal and ATP stimulated NO 2 - was not affected ( ) .'}]}]}]}]}]}
216	217	{'start':(0, 0), 'end':(0, 1), 'text':'Supplementary Material'}
